Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1951 1
1952 2
1954 1
1955 1
1957 1
1959 2
1962 1
1966 1
1967 1
1969 2
1970 1
1971 1
1973 2
1974 3
1976 5
1977 1
1982 1
1985 1
1991 1
1995 1
1997 1
2002 1
2003 1
2005 1
2007 1
2010 1
2011 2
2012 1
2013 3
2014 3
2015 4
2017 1
2018 5
2019 4
2020 6
2021 7
2022 5
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
[89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.
Shuch B, Pantuck AJ, Bernhard JC, Morris MA, Master V, Scott AM, van Praet C, Bailly C, Önal B, Aksoy T, Merkx R, Schuster DM, Lee ST, Pandit-Taskar N, Fan AC, Allman P, Schmidt K, Tauchmanova L, Wheatcroft M, Behrenbruch C, Hayward CRW, Mulders P. Shuch B, et al. Among authors: wheatcroft m. Lancet Oncol. 2024 Oct;25(10):1277-1287. doi: 10.1016/S1470-2045(24)00402-9. Epub 2024 Sep 10. Lancet Oncol. 2024. PMID: 39270701 Free article. Clinical Trial.
Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma.
Kleinendorst SC, Oosterwijk E, Molkenboer-Kuenen J, Frielink C, Franssen GM, Boreel DF, Tamborino G, Gloudemans M, Hendrikx M, Kroon D, Hillen J, Bussink J, Muselaers S, Mulders P, Konijnenberg MW, Wheatcroft MP, Twumasi-Boateng K, Heskamp S. Kleinendorst SC, et al. Among authors: wheatcroft mp. Theranostics. 2024 Jun 11;14(9):3693-3707. doi: 10.7150/thno.96944. eCollection 2024. Theranostics. 2024. PMID: 38948062 Free PMC article.
Key contact: Margaret Wheatcroft.
Wheatcroft M. Wheatcroft M. Prim Dent J. 2013 Jul;2(3):17. Prim Dent J. 2013. PMID: 24340494 No abstract available.
COMPASS for Vascular Surgeons: Practical Considerations.
Hussain MA, Wheatcroft M, Nault P, Lindsay TF, Bhatt DL, Anand SS, Verma S, Al-Omran M. Hussain MA, et al. Among authors: wheatcroft m. Curr Opin Cardiol. 2019 Mar;34(2):178-184. doi: 10.1097/HCO.0000000000000597. Curr Opin Cardiol. 2019. PMID: 30543542 Review.
Step, Error, and Event Frameworks in Endovascular Aortic Repair.
Gordon L, Soenens G, Doyen B, Sunavsky J, Wheatcroft M, de Mestral C, Palter V, Grantcharov T, Van Herzeele I. Gordon L, et al. Among authors: wheatcroft m. J Endovasc Ther. 2022 Dec;29(6):937-947. doi: 10.1177/15266028211068768. Epub 2022 Jan 11. J Endovasc Ther. 2022. PMID: 35012393
What is plaque?
Wheatcroft MG. Wheatcroft MG. J Am Soc Prev Dent. 1976 Jul-Aug;6(4):29. J Am Soc Prev Dent. 1976. PMID: 1074810 No abstract available.
DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of 177Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma.
Johnstone CN, Osellame LD, Cao Z, McDonald AF, Rigopoulos A, Burvenich IJG, Wichmann CW, Guo N, Ivashkevich AN, Wheatcroft MP, Yan EB, Zimmermann A, Zenke FT, Sirrenberg C, Scott FE, Scott AM. Johnstone CN, et al. Among authors: wheatcroft mp. J Nucl Med. 2025 Mar 3;66(3):385-390. doi: 10.2967/jnumed.124.268695. J Nucl Med. 2025. PMID: 39884775
83 results